NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/15/23 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
7 | |
| 12/08/23 | 8-K | Current report filing |
|
   |
2 |
| 12/08/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/29/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/13/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
97 |
| 11/07/23 | 8-K | Current report filing |
|
|
7 |
| 10/17/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/10/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/26/23 | 8-K | Current report filing |
|
|
2 |
| 09/25/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |